LENXOVIQ Trademark

Trademark Overview


On Wednesday, January 14, 2026, a trademark application was filed for LENXOVIQ with the United States Patent and Trademark Office. The USPTO has given the LENXOVIQ trademark a serial number of 99595030. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Thursday, February 26, 2026. This trademark is owned by Gilead Sciences Ireland UC. The LENXOVIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of viral infection, fungal infection, HIV infection, fibrosis, liver diseases and disorders, hepatitis, hematological diseases and disorders, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, respiratory and pulmonary diseases and disorders, kidney and nephrotic diseases and disorders, arthritis, obesity, metabolic diseases and disorders and gastrointestinal diseases and disorders; Pharmaceutical preparations for the prevention of HIV infection; Pharmaceutical preparations for the treatment and prevention of HIV infection
lenxoviq

General Information


Serial Number99595030
Word MarkLENXOVIQ
Filing DateWednesday, January 14, 2026
Status653 - SUSPENSION LETTER - MAILED
Status DateThursday, February 26, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of viral infection, fungal infection, HIV infection, fibrosis, liver diseases and disorders, hepatitis, hematological diseases and disorders, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, respiratory and pulmonary diseases and disorders, kidney and nephrotic diseases and disorders, arthritis, obesity, metabolic diseases and disorders and gastrointestinal diseases and disorders; Pharmaceutical preparations for the prevention of HIV infection; Pharmaceutical preparations for the treatment and prevention of HIV infection

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 14, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Trademark Events


Event DateEvent Description
Wednesday, January 14, 2026NEW APPLICATION ENTERED
Wednesday, January 14, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 14, 2026APPLICATION FILING RECEIPT MAILED
Thursday, February 19, 2026ASSIGNED TO EXAMINER
Friday, February 20, 2026NON-FINAL ACTION WRITTEN
Friday, February 20, 2026NON-FINAL ACTION E-MAILED
Friday, February 20, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 25, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 25, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 25, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 26, 2026SUSPENSION LETTER WRITTEN
Thursday, February 26, 2026LETTER OF SUSPENSION E-MAILED
Thursday, February 26, 2026NOTIFICATION OF LETTER OF SUSPENSION E-MAILED